MARC Record from marc_columbia

LEADER: 02272cam a2200469 a 4500
001 3957057
005 20221027005823.0
008 910530s1991 ne a b 101 0 eng c
010 $a 91009555
020 $a0444813837
035 $a(OCoLC)23213697
035 $a(OCoLC)ocm23213697
035 $a(CStRLIN)NYCM91-B2251
035 $9AFH4410HS
035 $a(NNC)3957057
035 $a3957057
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC662.4$b.I58 1991
060 0 $aW3 EX89 no. 930$aWK 820 I613 1990r
082 00 $a616.4/6207$220
111 2 $aInternational Symposium on Insulin Action and Its Disorders$d(1990 :$cŌtsu-shi, Japan)$0http://id.loc.gov/authorities/names/n89225741
245 10 $aRecent advances in insulin action and its disorders :$bproceedings of the International Symposium on Insulin Action and Its Disorders, Shiga, 16 May 1990 /$ceditors, Yukio Shigeta, Masashi Kobayashi, Jerrold M. Olefsky.
260 $aAmsterdam ;$aNew York :$bExcerpta Medica :$bNew York, NY, USA :$bSole distributors for the USA and Canada, Elsevier Science Pub. Co.,$c1991.
300 $avii, 157 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInternational congress series ;$vno. 930
500 $aIncludes index.
504 $aIncludes bibliographical references.
650 0 $aInsulin resistance$vCongresses.
650 0 $aInsulin$xPhysiological effect$vCongresses.
650 0 $aInsulin$xReceptors$vCongresses.
650 0 $aType 2 diabetes$vCongresses.
650 2 $aGlucose$xmetabolism.$0https://id.nlm.nih.gov/mesh/D005947Q000378
650 2 $aInsulin$xphysiology.$0https://id.nlm.nih.gov/mesh/D007328Q000502
650 2 $aReceptor, Insulin$xmetabolism.$0https://id.nlm.nih.gov/mesh/D011972Q000378
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aShigeta, Yukio,$d1929-$0http://id.loc.gov/authorities/names/n87843976
700 1 $aKobayashi, Masashi,$cDr.$0http://id.loc.gov/authorities/names/n89225740
700 1 $aOlefsky, Jerrold M.$0http://id.loc.gov/authorities/names/n84176253
830 0 $aInternational congress series ;$vno. 930.$0http://id.loc.gov/authorities/names/n42029631
852 00 $boff,hsl$hRC662.4$i.I58 1990